Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lønning PE, Brown PO, Børresen-Dale AL, Botstein D: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003, 100: 8418-8423. 10.1073/pnas.0932692100.
Article
CAS
PubMed
PubMed Central
Google Scholar
Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005, 365: 1687-1717. 10.1016/S0140-6736(05)66544-0.
Article
Google Scholar
Martin M, Pienkowski T, Mackey J, Pawlicki M, Guastalla JP, Weaver C, Tomiak E, Al-Tweigeri T, Chap L, Juhos E, Guevin R, Howell A, Fornander T, Hainsworth J, Coleman R, Vinholes J, Modiano M, Pinter T, Tang SC, Colwell B, Prady C, Provencher L, Walde D, Rodriguez-Lescure A, Hugh J, Loret C, Rupin M, Blitz S, Jacobs P, Murawsky M, et al: Adjuvant docetaxel for node-positive breast cancer. N Engl J Med. 2005, 352: 2302-2313. 10.1056/NEJMoa043681.
Article
CAS
PubMed
Google Scholar
Rowinsky EK, Donehower RC: Paclitaxel (taxol). N Engl J Med. 1995, 332: 1004-1014. 10.1056/NEJM199504133321507.
Article
CAS
PubMed
Google Scholar
Crown J, O'Leary M, Ooi WS: Docetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experience. Oncologist. 2004, 9 (Suppl 2): 24-32. 10.1634/theoncologist.9-suppl_2-24.
Article
CAS
PubMed
Google Scholar
Nowak AK, Wilcken NR, Stockler MR, Hamilton A, Ghersi D: Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer. Lancet Oncol. 2004, 5: 372-380. 10.1016/S1470-2045(04)01494-9.
Article
CAS
PubMed
Google Scholar
Ward S, Simpson E, Davis S, Hind D, Rees A, Wilkinson A: Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation. Health Technol Assess. 2007, 11: 1-144.
Google Scholar
Ring BZ, Seitz RS, Beck R, Shasteen WJ, Tarr SM, Cheang MC, Yoder BJ, Budd GT, Nielsen TO, Hicks DG, Estopinal NC, Ross DT: Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer. J Clin Oncol. 2006, 24: 3039-3047. 10.1200/JCO.2006.05.6564.
Article
CAS
PubMed
Google Scholar
Jennings BH, Ish-Horowicz D: The Groucho/TLE/Grg family of transcriptional co-repressors. Genome Biol. 2008, 9: 205-10.1186/gb-2008-9-1-205.
Article
PubMed
PubMed Central
Google Scholar
Terry J, Saito T, Subramanian S, Ruttan C, Antonescu CR, Goldblum JR, Downs-Kelly E, Corless CL, Rubin BP, Rijn van de M, Ladanyi M, Nielsen TO: TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Am J Surg Pathol. 2007, 31: 240-246. 10.1097/01.pas.0000213330.71745.39.
Article
PubMed
Google Scholar
Chen G, Courey AJ: Groucho/TLE family proteins and transcriptional repression. Gene. 2000, 249: 1-16. 10.1016/S0378-1119(00)00161-X.
Article
CAS
PubMed
Google Scholar
Liu Y, Dehni G, Purcell KJ, Sokolow J, Carcangiu ML, Artavanis-Tsakonas S, Stifani S: Epithelial expression and chromosomal location of human TLE genes: implications for notch signaling and neoplasia. Genomics. 1996, 31: 58-64. 10.1006/geno.1996.0009.
Article
CAS
PubMed
Google Scholar
Leon C, Lobe CG: Grg3, a murine Groucho-related gene, is expressed in the developing nervous system and in mesenchyme-induced epithelial structures. Dev Dyn. 1997, 208: 11-24. 10.1002/(SICI)1097-0177(199701)208:1<11::AID-AJA2>3.0.CO;2-4.
Article
CAS
PubMed
Google Scholar
Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, Alexander KE, Matese JC, Perou CM, Hurt MM, Brown PO, Botstein D: Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell. 2002, 13: 1977-2000. 10.1091/mbc.02-02-0030..
Article
CAS
PubMed
PubMed Central
Google Scholar
Symmans WF, Peintinger F, Hatzis C, Rajan R, Kuerer H, Valero V, Assad L, Poniecka A, Hennessy B, Green M, Buzdar AU, Singletary SE, Hortobagyi GN, Pusztai L: Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol. 2007, 25: 4414-4422. 10.1200/JCO.2007.10.6823.
Article
PubMed
Google Scholar
Allen T, van Tuyl M, Iyengar P, Jothy S, Post M, Tsao MS, Lobe CG: Grg1 acts as a lung-specific oncogene in a transgenic mouse model. Cancer Res. 2006, 66: 1294-1301. 10.1158/0008-5472.CAN-05-1634.
Article
CAS
PubMed
Google Scholar
Nakaya HI, Beckedorff FC, Baldini ML, Fachel AA, Reis EM, Verjovski-Almeida S: Splice variants of TLE family genes and up-regulation of a TLE3 isoform in prostate tumors. Biochem Biophys Res Commun. 2007, 364: 918-923. 10.1016/j.bbrc.2007.10.097.
Article
CAS
PubMed
Google Scholar
Hasson P, Egoz N, Winkler C, Volohonsky G, Jia S, Dinur T, Volk T, Courey AJ, Paroush Z: EGFR signaling attenuates Groucho-dependent repression to antagonize Notch transcriptional output. Nat Genet. 2005, 37: 101-105.
CAS
PubMed
Google Scholar
Hasson P, Paroush Z: Crosstalk between the EGFR and other signalling pathways at the level of the global transcriptional corepressor Groucho/TLE. Br J Cancer. 2007, 96 (Suppl): R21-25.
PubMed
Google Scholar
van Agthoven T, Sieuwerts AM, Meijer-van Gelder ME, Look MP, Smid M, Veldscholte J, Sleijfer S, Foekens JA, Dorssers LC: Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance. J Clin Oncol. 2009, 27: 542-549. 10.1200/JCO.2008.17.1462.
Article
PubMed
Google Scholar
van Agthoven T, Veldscholte J, Smid M, van Agthoven TL, Vreede L, Broertjes M, de Vries I, de Jong D, Sarwari R, Dorssers LC: Functional identification of genes causing estrogen independence of human breast cancer cells. Breast Cancer Res Treat. 2009, 114: 23-30. 10.1007/s10549-008-9969-5.
Article
PubMed
Google Scholar
Sekiya T, Zaret KS: Repression by Groucho/TLE/Grg proteins: genomic site recruitment generates compacted chromatin in vitro and impairs activator binding in vivo. Mol Cell. 2007, 28: 291-303. 10.1016/j.molcel.2007.10.002.
Article
CAS
PubMed
PubMed Central
Google Scholar
Andre F, Hatzis C, Anderson K, Sotiriou C, Mazouni C, Mejia J, Wang B, Hortobagyi GN, Symmans WF, Pusztai L: Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer. Clin Cancer Res. 2007, 13: 2061-2067. 10.1158/1078-0432.CCR-06-2078.
Article
CAS
PubMed
Google Scholar
Pusztai L: Markers predicting clinical benefit in breast cancer from microtubule-targeting agents. Ann Oncol. 2007, 18 (Suppl 12): xii15-20. 10.1093/annonc/mdm534.
PubMed
Google Scholar
Hayes DF, Thor AD, Dressler LG, Weaver D, Edgerton S, Cowan D, Broadwater G, Goldstein LJ, Martino S, Ingle JN, Henderson IC, Norton L, Winer EP, Hudis CA, Ellis MJ, Berry DA, Cancer and Leukemia Group B (CALGB) Investigators: HER2 and response to paclitaxel in node-positive breast cancer. N Engl J Med. 2007, 357: 1496-1506. 10.1056/NEJMoa071167.
Article
CAS
PubMed
Google Scholar
Sparano JA, Wang M, Martino S, Jones V, Perez EA, Saphner T, Wolff AC, Sledge GW, Wood WC, Davidson NE: Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med. 2008, 358: 1663-1671. 10.1056/NEJMoa0707056.
Article
CAS
PubMed
PubMed Central
Google Scholar